Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Barw Medical Journal · 16.11.2024
DOI: 10.58742/bmj.v2i4.138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Barw Medical Journal, online erschienen am 16.11.2024. Verfasst von Ayman M. Mustafa und 14 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acquired and hospital-acquired infections (HAIs). This study compares these microorganisms and explores their relationship with patients' comorbidities and socio-demographic factors.
Methods
This retrospective cross-sectional study was conducted at Smart Health Tower, Iraq, from January to December 2023, focusing on patients with community-acquired infections and HAIs. Data were extracted from microbiology laboratory records, including blood cultures, urine samples, and other body fluids, with patients classified based on CDC and IDSA guidelines. Bacterial identification combined conventional methods and the BD Phoenix™ M50 system, while antibiotic susceptibility was tested using the Kirby-Bauer method and the same automated system. Statistical analysis of resistance patterns utilized SPSS version 25, with significance set at p ≤ 0.05.
Results
In this study of 2,157 participants, 1,303 (60.4%) were male, with microbial growth observed in 1,177 cases (54.6%). Notably, 41.1% of females and 52.1% of males showed no growth (p < 0.001). The mean age was 43.62 ± 23.3 years. Wound samples had the highest growth rate (91.2%), while body fluids had the lowest (33.0%) (p < 0.001). The overall multidrug resistance rates were 62.5% for community-acquired infections and 79.3% for HAIs. Patients with pre-existing comorbidities demonstrated significantly higher rates of hospital-acquired infections (p < 0.05).
Conclusion
Multidrug-resistant isolates are more prevalent in HAIs than in community-acquired infections, highlighting the need for enhanced surveillance to optimize antibiotic use and control HAIs through early detection of resistance.
Introduction
Hospitals represent a potentially hazardous environment due to various virulent pathogens introduced by admitted patients from the community. These patients are subsequently exposed not only to the hospital's endemic flora but also to microorganisms carried by other ill individuals [1]. This occurs due to a compromised immune defense and colonization by resistant organisms [2]. Hospital-acquired infections (HAIs) are a frequent occurrence in healthcare facilities globally, with their prevalence exceptionally high in resource-limited developing countries [3]. The extensive use of broad-spectrum antibiotics in hospitals creates an intense selective pressure, fostering the emergence of antibiotic-resistant bacteria and complicating the treatment of these infections. As a result, HAIs have been recognized as a severe public health issue for over a century, contributing to poor health outcomes and significantly impacting the quality of healthcare delivery [4]. Hospital-acquired infections most commonly manifest as urinary tract infections, respiratory tract infections, circulatory system infections, and surgical site infections [5]. A World Health Organization report covering 55 hospitals across 14 countries found that 8.7% of hospitalized patients developed HAIs, with the highest prevalence observed in the Eastern Mediterranean Region and lower rates in the Western Pacific [5]. The prevalence of HAIs has been reported at approximately 5% in North America and parts of Europe while reaching up to 40% in some areas of Asia, Latin America, and Africa [6]. A European study reported the prevalence of HAIs to be approximately 2.9%. Several factors contribute to the occurrence of HAIs, including medical interventions, substandard hospital environments, and inadequate personal hygiene practices among both hospital staff and patients [7]. However, the primary driver of HAIs is the failure to adhere to health and safety protocols in healthcare settings. While it is impossible to eliminate HAIs, even in highly advanced hospitals, strict adherence to established standards and guidelines can significantly reduce or manage their occurrence, especially in regions such as Africa [6]. In modern healthcare, where technological advancements and high expectations for quality care prevail, it is critical to thoroughly examine the frequency and underlying causes of HAIs. The absence of accurate data on the prevalence of HAIs poses significant challenges to executing these control measures, leading to increased healthcare costs for both health systems and patients [8]. Despite the global recognition of these pathogens, limited studies have compared microorganisms from both community and hospital settings; therefore, the current study aims to fill this gap by comparing microorganisms isolated from community-acquired and HAIs. It also seeks to explore the relationship between these infections and patients' comorbidities and socio-demographic factors.
Methods
Study design and setting This retrospective cross-sectional study was conducted at Smart Health Tower, Iraq, between January 2023 and December 2023. It included patients from various departments of the hospital, with infections categorized as either community-acquired or HAIs. The Kscien Organization approved the study for Ethical Approval, reference number 24/No. 27, ensuring all ethical guidelines were followed throughout the study. Sample collection and study population Data were meticulously extracted from the records of patients who had their samples processed in the microbiology laboratory. Inclusion criteria encompassed all available clinical samples, including blood cultures, urine samples, sputum and bronchoalveolar lavage, wound swabs, and other body fluids. Patients were classified into either the CAI or HAI group based on guidelines from the Centers for Disease Control and Prevention and the Infectious Diseases Society of America. The CAIs were defined as infections present at the time of hospital admission or within 48 hours of admission, with no history of recent healthcare exposure, such as hospitalization within the previous 90 days. In contrast, HAIs were defined as infections that developed 48 hours or more after hospital admission and were associated with invasive procedures or prior healthcare exposure [9]. Patients with incomplete data were excluded to ensure the accuracy and reliability of the study findings. Bacterial identification Bacterial identification was conducted using conventional methods and the BD Phoenix™ M50 automated identification and susceptibility testing system, specifically tailored to the diverse range of clinical samples processed during the study. Blood cultures were incubated in the BD BACTEC™ automated blood culture system, following established protocols, for up to five days to detect the growth of bacteria or fungi, with positive cultures subsequently sub-cultured onto solid media, including blood agar and chocolate agar, to enhance isolation of pathogens. Urine samples were plated on cystine lactose electrolyte-deficient agar and MacConkey agar to promote the growth of Escherichia coli, Klebsiella, and other common uropathogens. Body fluids were inoculated onto blood and chocolate agar. To identify respiratory pathogens, sputum samples were Gram-stained and cultured on selective media, including MacConkey and blood agar. Wound swabs were processed on blood agar and mannitol salt agar. The BD Phoenix™ M50 system was utilized for precise species-level identification and antimicrobial susceptibility testing, providing comprehensive biochemical profiles for various pathogens [10]. This combination of conventional and automated methods ensured accurate identification and susceptibility testing across all clinical sample types, adhering to CLSI (Clinical and Laboratory Standards Institute) guidelines for bacteriological analysis [11]. For samples that did not exhibit visible growth after the initial 24 hours, the incubation was extended to 48 hours. Antibiotic susceptibility testing Antimicrobial susceptibility testing was conducted using two methods. The classical Kirby-Bauer disk diffusion method was performed according to Clinical and Laboratory Standards Institute guidelines [11], where standardized antibiotic disks were applied to Mueller-Hinton agar plates inoculated with bacterial suspensions, and inhibition zone diameters were measured and interpreted using CLSI breakpoints (Figure 1). Additionally, the BD Phoenix™ M50 automated system was used to confirm susceptibility results and to test a broader range of antimicrobials, providing Minimum Inhibitory Concentration (MIC) values and classifying isolates as susceptible, intermediate, or resistant based on CLSI interpretive criteria. The antibiotics tested included Amikacin, Gentamicin, Gentamicin-Syn, Ampicillin-sulbactam, Ampicillin, Amoxicillin, Amoxicillin-Clavulanate, Piperacillin-Tazobactam, Piperacillin, Penicillin G, Oxacillin, Cefuroxime, Ceftriaxone, Cefepime, Cefoxitin, Ceftaroline, Cefpodoxime, Cefixime, Cefotaxime, Clarithromycin, Azithromycin, Erythromycin, Ciprofloxacin, Levofloxacin, Moxifloxacin, Norfloxacin, Ofloxacin, Trimethoprim-Sulfamethoxazole, Vancomycin, Teicoplanin, Daptomycin, Clindamycin, Tetracycline, Doxycycline, Minocycline, Tigecycline, Imipenem, Meropenem, Nitrofurantoin, Linezolid, Rifampin, Chloramphenicol, Mupirocin High level. This combined approach ensured consistent and accurate interpretation of susceptibility results, enhancing the reliability of the findings. Antibiotic classification and multidrug resistance The antibiotics were categorized into seven groups: aminoglycosides, beta-lactams, macrolides, sulfonamides, tetracyclines, glycopeptides, and fluoroquinolones. Multidrug-resistant (MDR) isolates were defined as bacterial strains resistant to three or more of these antibiotic classes, following established criteria [12]. This classification facilitated a comprehensive analysis of antimicrobial resistance patterns and enabled the identification of the most challenging cases of antibiotic resistance, providing critical insight into the prevalence of MDR organisms. Data analysis Data on bacterial isolates, antimicrobial susceptibility profiles, patient demographics, infection types, and antibiotic resistance patterns were systematically collected and entered into Microsoft Excel 2007 before being transferred to SPSS version 25 for statistical analysis. Statistical evaluations were conducted to assess differences in resistance rates between CAIs and HAIs, stratified by infection site (e.g., bloodstream, urinary tract, respiratory tract) and pathogen type. Descriptive statistics summarized the demographic and clinical characteristics of patients, while resistance rates were compared using Chi-square tests for categorical variables and t-tests for continuous variables. The analysis encompassed calculating prevalence rates, frequencies, susceptibility patterns, and other descriptive statistics, with statistical significance set at a p-value of equal to or less than 0.05 for the chi-square test, which compared categorical variables with bacterial growth.
Results
Microbial growth and participant characteristics In this study involving 2157 participants, 1303 (60.4%) were male. Microbial growth was observed in 1177 cases (54.6%). Notably, 535 (41.1%) of the females and 445 (52.1%) of the males exhibited no growth, indicating a significant difference (p < 0.001). The mean age of participants was 43.62± 23.3years. The highest growth rate was observed in wound samples (187, 91.2%), while body fluids showed the lowest rate (171, 33.0%), reflecting a statistically significant difference (p < 0.001). The sample collection location did not significantly influence growth, with no growth in 475 (44.7%) from community settings and 216 (46.7%) from hospitals (p = 0.502). Among the various comorbidities, obesity, renal insufficiency, and diabetes, significantly differed between participants with microbial growth and those without growth(P
Zitieren
APA
Mustafa, A. M., Salih, R. Q., Yaseen, H. A., Hamadameen, W. A., Kakamad, S. H., Abdullah, F., Mohammed, K. K., Hamad, D. Q., Ismaeel, B. H., Abdullah, H. S., Ahmed, S. H., Abdalla, B. A., Kakamad, F. H., Salih, M. O., & Abdalla, S. S. (2024). Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections. Barw Medical Journal. https://doi.org/10.58742/bmj.v2i4.138
Vancouver
Mustafa AM, Salih RQ, Yaseen HA, Hamadameen WA, Kakamad SH, Abdullah F, et al. Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections. Barw Medical Journal. 2024. doi:10.58742/bmj.v2i4.138
BibTeX
@article{Mustafa2024,
author = {Mustafa, Ayman M. and Salih, Rawezh Q. and Yaseen, Hidayat A. and Hamadameen, Wafa A. and Kakamad, Suhaib H. and Abdullah, Fakher and Mohammed, Karokh K. and Hamad, Dyari Q. and Ismaeel, Brwa H. and Abdullah, Hawnaz S. and Ahmed, Shnya H. and Abdalla, Berun A. and Kakamad, Fahmi H. and Salih, Miran O. and Abdalla, Sarhang S.},
title = {Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections},
journal = {Barw Medical Journal},
year = {2024},
doi = {10.58742/bmj.v2i4.138}
}
EUVIMED